ACG 2017: Ozanimod Maintains Efficacy and Safety Up to 2 Years in Moderate to Severe Ulcerative Colitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Only registered members have full access to PracticeUpdate content.